Rationale and proposed framework for shared decision making in cardio-oncology.

Autonomy Ethics Shared decision making

Journal

Cardio-oncology (London, England)
ISSN: 2057-3804
Titre abrégé: Cardiooncology
Pays: England
ID NLM: 101689938

Informations de publication

Date de publication:
23 Aug 2021
Historique:
received: 28 06 2021
accepted: 12 08 2021
entrez: 24 8 2021
pubmed: 25 8 2021
medline: 25 8 2021
Statut: epublish

Résumé

Physicians have a duty to present diagnostic and therapeutic choices with rational guidance that respects patient values and realizes patient goals. In cardio-oncology, we commonly encounter patients who understandably feel overwhelmed or feel that they have no favorable options, particularly in the context of advanced malignancy. Accordingly, a longitudinal multidisciplinary commitment to shared decision making (SDM) ensures that physicians and patients actively participate in this process to promote the best possible outcomes from the patient perspective. We propose a practical framework for approaching these difficult decisions in cardio-oncology drawing upon our experience in clinical practice.

Identifiants

pubmed: 34425913
doi: 10.1186/s40959-021-00118-7
pii: 10.1186/s40959-021-00118-7
pmc: PMC8380868
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

30

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : american heart association
ID : 18CDA34110361

Informations de copyright

© 2021. The Author(s).

Références

JACC Cardiovasc Imaging. 2018 Aug;11(8):1209-1211
pubmed: 30092977
Front Cardiovasc Med. 2020 Mar 18;7:26
pubmed: 32258060
J Am Heart Assoc. 2020 Jan 21;9(2):e013757
pubmed: 31960755
N Engl J Med. 2012 Mar 1;366(9):780-1
pubmed: 22375967
J Natl Cancer Inst. 2021 May 4;113(5):513-522
pubmed: 33179744
Circ Cardiovasc Qual Outcomes. 2014 May;7(3):487-92
pubmed: 24714602
Hypertension. 2018 Feb;71(2):e1-e8
pubmed: 29279311
J Pers Soc Psychol. 2000 Dec;79(6):995-1006
pubmed: 11138768
Circulation. 2012 Apr 17;125(15):1928-52
pubmed: 22392529
J Clin Oncol. 2016 Apr 1;34(10):1030-3
pubmed: 26834055
J Am Coll Cardiol. 2009 Apr 28;53(17):1475-87
pubmed: 19389557
J Clin Oncol. 2018 Oct 20;36(30):2975-2977
pubmed: 30169115
Hastings Cent Rep. 1972 Jun;2(3):5-7
pubmed: 4679693

Auteurs

Sarah C Hull (SC)

Section of Cardiovascular Medicine, Yale School of Medicine, 20 York Street, New Haven, CT, 06510, USA. sarah.hull@yale.edu.
Program for Biomedical Ethics, Yale School of Medicine, 20 York Street, New Haven, CT, 06510, USA. sarah.hull@yale.edu.

Aaron Soufer (A)

Section of Cardiovascular Medicine, Yale School of Medicine, 20 York Street, New Haven, CT, 06510, USA.

Erica S Spatz (ES)

Section of Cardiovascular Medicine, Yale School of Medicine, 20 York Street, New Haven, CT, 06510, USA.
Yale Center for Outcomes Research and Evaluation, New Haven, CT, USA.

Lauren A Baldassarre (LA)

Section of Cardiovascular Medicine, Yale School of Medicine, 20 York Street, New Haven, CT, 06510, USA.

Classifications MeSH